C

SEC EDGAR - Form 4 insider activity

Cue Biopharma, Inc. $CUE

Tracked equity - 3 filings indexed by Nortis

Nortis signal thesis

Cluster activity detected. Review whether the filings are open-market trades or routine compensation events.

0

OM buys - 90d

3

OM sells - 90d

0

Routine filings

3

Cluster filings

$275.0K

Largest trade

62/100

Avg signal score

Filing tape

Recent filings

Last 30d: 3
Open-market SellCLUSTERNotable 65/100
filed 2026-10-15
RSOfficer

Ray Sumita - Chief Legal Compliance Officer, Corporate Secretary - $51.7K

Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Open-market SellCLUSTERNotable 50/100
filed 2026-10-15
MVOfficer

Meluzio Michael Vincent - VP, Prin. Accounting Officer - $32.1K

Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Open-market SellCLUSTERHigh signal 71/100
filed 2026-10-15
LSCEO

Lin Shao-Lee - Director, Chief Executive Officer - $275.0K

Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing